Published 2 years ago

Pfizer requests FDA authorization for booster dose to children 5-11

Summary by Ground News

Pfizer has asked the FDA to authorize a booster dose of its COVID vaccine for 5- to 11-year-olds. U.S. health authorities already urge everyone 12 and older to get one booster dose. In a small study, 140 youngsters who'd already gotten two shots were given a booster. Researchers found the extra shot revved up their immune response.

0 Articles

All

Left

Center

Right

CTV News

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

Pfizer Inc and its partner BioNTech SE said on Tuesday that they had submitted an application to the U.S. health regulator for the authorization of a booster dose of their COVID-19 vaccine for children aged 5 to 11 years.

2 years ago·Canada

Read Full Article

Reuters

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

2 years ago·United Kingdom

Read Full Article

USA Today

Pfizer-BioNTech seeks FDA authorization for a COVID booster shot for kids 5-11

A study showed a strong immune response to a booster shot among healthy children in that age group.

2 years ago·United States

Read Full Article

Global News

Pfizer seeks U.S. approval of COVID-19 booster for children aged 5-11 - National

Pfizer and BioNTech have filed for the clearance of a 10-microgram booster dose for children 5 to 11 years.

2 years ago·Toronto, Canada

Read Full Article

CNN

Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11 | CNN

Pfizer and BioNTech said Tuesday that they have submitted an application to the US Food and Drug Administration for emergency use authorization of a booster dose of Covid-19 vaccine for children 5 through 11.

2 years ago·Atlanta, United States

Read Full Article

CNBC

Pfizer Asks FDA to Authorize Third Dose for Children 5 to 11 Years Old

Pfizer on Tuesday asked the Food and Drug Administration to authorize a third dose of its COVID vaccine for children ages 5- to 11-years-old. The application comes after Pfizer released data earlier this month from a small lab study of blood samples from 30 kids in the age group, which showed a 36-fold increase in antibody levels against the omicron variant…

2 years ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left8Leaning Right4Center39Last Updated2 years agoBias Distribution

76% Center

Bias Distribution

76% of the sources are Center

76% Center

+34

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Pfizer requests FDA authorization for booster dose to children 5-11

0 Articles

0 Articles

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

Pfizer-BioNTech seeks FDA authorization for a COVID booster shot for kids 5-11

Pfizer-BioNTech seeks FDA authorization for a COVID booster shot for kids 5-11

Pfizer seeks U.S. approval of COVID-19 booster for children aged 5-11 - National

Pfizer seeks U.S. approval of COVID-19 booster for children aged 5-11 - National

Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11 | CNN

Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11 | CNN

Pfizer Asks FDA to Authorize Third Dose for Children 5 to 11 Years Old

Pfizer Asks FDA to Authorize Third Dose for Children 5 to 11 Years Old

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics